Aquaculture Vaccines Market: By Vaccine Type, By Application, By Route of Administration, By Species, and Region Forecast 2020-2031

download arrow download arrow Download Sample
settings arrow settings arrow email us

Aquaculture Vaccines Market Size, Share, Growth, Trends, and Global Industry Analysis: By Vaccine Type (Inactivated Vaccine, Attenuated Live Vaccine, DNA Vaccine, and Others), By Application (Bacterial Infection, Viral Infections, Combined Bacterial and Viral Infections, and Others), By Route of Administration (Immersion Vaccines, Injection Vaccines, and Oral Vaccines), By Species (Salmon, Seabass,  Seabream, Tilapia, Trout, Turbot, and Carp), and Region Forecast 2020-2031

checked icon checked icon arrow_drop_down
checked icon Single User License $4400 $3520
checked icon Multiple User License $6600 $5280
checked icon Corporate User License $8900 $7120

Aquaculture Vaccines Market size was valued at US$ 465.9 million in 2024 and is expected to reach US$ 768.0 million by 2031, growing at a significant CAGR of 7.4% from 2025-2031. Due to surge in the of prevalence of bacterial and viral infections among aquaculture species, increase in aquaculture production around the globe, and rise in adoption of vaccines by aquaculture farmers. Development and launch of innovative vaccines to treat various infectious diseases in aquaculture species boosting the revenue growth of the market.

For instance, In March 2018, Hipra launched Icthiovac VR/PD injectable vaccine for seabass against Vibriosis and Pasteurellosis in Greece. Apart from the aforementioned dynamics, Raise in funding for the research and development of innovative aquaculture vaccines boost the market over forecast years. For instance, In March 2015, The Scottish Aquaculture Innovation Center (SAIC) has announced it is issuing grants worth almost GBP 950,000 to two major salmon farming research projects proposed by leading farmed salmon companies on sea lice and salmon vaccinations.   

Key Development

  • In April 2021, CIBA launched Nodavac-R, an injectable recombinant viral nervous necrosis (VNN) vaccine that can effectively prevent VNN caused by RGNNV in fingerlings and prevent vertical transmission in brooders. All fish species, including milkfish, grey mullet, and mangrove red snapper susceptible to VNN, can use the Nodavac-R. CIBA is also developing an oral vaccine that can administer through feed and immersion.
  • In November 2019, MSD Animal Health launched the AQUAVAC® Strep Sa-Si injectable and dip immersion vaccine against Streptococcis in tilapia fish in Latin America.

summary download arrow Download Sample

Global Aquaculture Vaccines Market Summary

Study Period

2025-2031

Base Year

2024

CAGR

7.9%

Largest Market

Asia-Pacific

Fastest Growing Market

Asia-Pacific

Aquaculture Vaccine Market Dynamics

Increase in the fish mortality due to certain disease outbreaks driving the growth of the market. For instance, in October 2017, approximately 125,000 salmon have died due to a disease outbreak at two fish farms on the Isle of Lewis due to bacterium Pasturella Skyensis infection.

In addition, surge in population demand for the healthy fish products, demand for animal protein, government support for the aquaculture immunization programs, rise in adoption of aquaculture vaccines in the developed and developing nations are boost the market over the forecast years. Moreover, increase in the international trading of aquaculture species immense boost the global aquaculture vaccines over the forecast period.

Global Aquaculture Vaccines Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2025-2031

Market Size in 2024

US$ 465.9 million

Market Size in 2031

US$ 768.0 million

Market CAGR

7.9%

By Vaccine Type

  • Inactivated Vaccine
  • Attenuated Live Vaccine
  • DNA Vaccine
  • Others

By Application

  • Bacterial Infection
  • Viral Infections
  • Combined Bacterial
  • Viral Infections and
  • Others

By Route of Administration

  • Immersion Vaccines
  • Injection Vaccines
  • Oral Vaccines

By Species

  • Salmon
  • Seabass and Seabream
  • Tilapia
  • Trout
  • Turbot
  • Carp

By Region

  • North America (U.S., Canada)
  • Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
  • Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)
  • Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America)
  • Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)

Key Features of the Report

  • The aquaculture vaccines market report provides granular level information about the market size, regional market share, historic market (2020-2024), and forecast (2025-2031)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porters Five Force Analysis

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

Aquaculture vaccines market size was valued at US$ 465.9 million in 2024 and is expected to reach US$ 768.0 million by 2031, growing at a significant CAGR of 7.4% from 2025-2031.

Inactivated vaccine type dominates the aquaculture vaccine product segment.

Norway is the big market.

Zoetis (Pharmaq), MSD Animal Health, Elanco, and Virbac are the key market players in the market.

Author image

Author

Manoj Kumar

Manoj Kumar is a postgraduate in Life Sciences with over seven years of dedicated experience in the fields of anima.....

1.Executive Summary
2.Global Aquaculture Vaccines Market Introduction 
2.1.Global Aquaculture Vaccines Market  - Taxonomy
2.2.Global Aquaculture Vaccines Market  - Definitions
2.2.1.Vaccine Type
2.2.2.Application
2.2.3. Route of Administration
2.2.4.Species 
2.2.5.Region
3.Global Aquaculture Vaccines Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Aquaculture Vaccines Market Analysis, 2020 - 2024 and Forecast 2025 - 2031
4.1.  Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Aquaculture Vaccines Market  By Vaccine Type, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
5.1. Inactivated Vaccine,
5.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Attenuated Live Vaccine,
5.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. DNA Vaccine, and
5.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Others
5.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
6.Global Aquaculture Vaccines Market  By Application, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
6.1. Bacterial Infection,
6.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Viral Infections,
6.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Combined Bacterial and Viral Infections, and
6.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Others
6.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
7.Global Aquaculture Vaccines Market  By  Route of Administration, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
7.1. Immersion Vaccines,
7.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Injection Vaccines, and
7.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Oral Vaccines
7.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
8.Global Aquaculture Vaccines Market  By Species , 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
8.1. Salmon,
8.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Seabass and Seabream,
8.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Tilapia,
8.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Trout,
8.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Turbot, and
8.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
8.6. Carp
8.6.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
8.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.6.3. Market Opportunity Analysis 
9.Global Aquaculture Vaccines Market  By Region, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
9.1. North America
9.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.1.3. Market Opportunity Analysis 
9.2. Europe
9.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.2.3. Market Opportunity Analysis 
9.3. Asia Pacific (APAC)
9.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.3.3. Market Opportunity Analysis 
9.4. Middle East and Africa (MEA)
9.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.4.3. Market Opportunity Analysis 
9.5. Latin America
9.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.5.3. Market Opportunity Analysis 
10.North America Aquaculture Vaccines Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
10.1. Vaccine Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Inactivated Vaccine,
10.1.2.Attenuated Live Vaccine,
10.1.3.DNA Vaccine, and
10.1.4.Others
10.2.  Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Bacterial Infection,
10.2.2.Viral Infections,
10.2.3.Combined Bacterial and Viral Infections, and
10.2.4.Others
10.3.   Route of Administration Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Immersion Vaccines,
10.3.2.Injection Vaccines, and
10.3.3.Oral Vaccines
10.4.  Species  Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Salmon,
10.4.2.Seabass and Seabream,
10.4.3.Tilapia,
10.4.4.Trout,
10.4.5.Turbot, and
10.4.6.Carp
10.5.  Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.5.1.United States of America (USA)
10.5.2.Canada
11.Europe Aquaculture Vaccines Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
11.1. Vaccine Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Inactivated Vaccine,
11.1.2.Attenuated Live Vaccine,
11.1.3.DNA Vaccine, and
11.1.4.Others
11.2.  Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Bacterial Infection,
11.2.2.Viral Infections,
11.2.3.Combined Bacterial and Viral Infections, and
11.2.4.Others
11.3.   Route of Administration Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Immersion Vaccines,
11.3.2.Injection Vaccines, and
11.3.3.Oral Vaccines
11.4.  Species  Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.Salmon,
11.4.2.Seabass and Seabream,
11.4.3.Tilapia,
11.4.4.Trout,
11.4.5.Turbot, and
11.4.6.Carp
11.5.  Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.5.1.Germany
11.5.2.France
11.5.3.Italy
11.5.4.United Kingdom (UK)
11.5.5.Spain
12.Asia Pacific (APAC) Aquaculture Vaccines Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
12.1. Vaccine Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Inactivated Vaccine,
12.1.2.Attenuated Live Vaccine,
12.1.3.DNA Vaccine, and
12.1.4.Others
12.2.  Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Bacterial Infection,
12.2.2.Viral Infections,
12.2.3.Combined Bacterial and Viral Infections, and
12.2.4.Others
12.3.   Route of Administration Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Immersion Vaccines,
12.3.2.Injection Vaccines, and
12.3.3.Oral Vaccines
12.4.  Species  Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.Salmon,
12.4.2.Seabass and Seabream,
12.4.3.Tilapia,
12.4.4.Trout,
12.4.5.Turbot, and
12.4.6.Carp
12.5.  Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.5.1.China
12.5.2.India
12.5.3.Australia and New Zealand (ANZ)
12.5.4.Japan
12.5.5.Rest of APAC
13.Middle East and Africa (MEA) Aquaculture Vaccines Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
13.1. Vaccine Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Inactivated Vaccine,
13.1.2.Attenuated Live Vaccine,
13.1.3.DNA Vaccine, and
13.1.4.Others
13.2.  Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Bacterial Infection,
13.2.2.Viral Infections,
13.2.3.Combined Bacterial and Viral Infections, and
13.2.4.Others
13.3.   Route of Administration Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Immersion Vaccines,
13.3.2.Injection Vaccines, and
13.3.3.Oral Vaccines
13.4.  Species  Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Salmon,
13.4.2.Seabass and Seabream,
13.4.3.Tilapia,
13.4.4.Trout,
13.4.5.Turbot, and
13.4.6.Carp
13.5.  Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.5.1.GCC Countries
13.5.2.South Africa
13.5.3.Rest of MEA
14.Latin America Aquaculture Vaccines Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
14.1. Vaccine Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.1.1.Inactivated Vaccine,
14.1.2.Attenuated Live Vaccine,
14.1.3.DNA Vaccine, and
14.1.4.Others
14.2.  Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.2.1.Bacterial Infection,
14.2.2.Viral Infections,
14.2.3.Combined Bacterial and Viral Infections, and
14.2.4.Others
14.3.   Route of Administration Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.3.1.Immersion Vaccines,
14.3.2.Injection Vaccines, and
14.3.3.Oral Vaccines
14.4.  Species  Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.4.1.Salmon,
14.4.2.Seabass and Seabream,
14.4.3.Tilapia,
14.4.4.Trout,
14.4.5.Turbot, and
14.4.6.Carp
14.5.  Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.5.1.Brazil
14.5.2.Mexico
14.5.3.Rest of LA
15. Competition Landscape
15.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
15.2.1.Pharmaq AS (Zoetis, LLC) (Norway)
15.2.2.Merck Animal Health (Merck & Co., Inc.) (USA)
15.2.3.KoVax Ltd. (Part of Phibro Animal Health) (Israel)
15.2.4.Hipra (Spain)
15.2.5.Tecnovax SA (Argentina)
15.2.6.Veterquimica S.A. (Chile)
15.2.7.Nisseiken Co. Ltd. (Japan)
15.2.8.Virbac S.A. (France)
15.2.9.Elanco (USA)
15.2.10.Kyoritsuseiyaku Corporation (Japan)
16. Research Methodology 
17. Appendix and Abbreviations 

Key Market Players

  • Pharmaq AS (Zoetis, LLC) (Norway)
  • Merck Animal Health (Merck & Co., Inc.) (USA)
  • KoVax Ltd. (Part of Phibro Animal Health) (Israel)
  • Hipra (Spain)
  • Tecnovax SA (Argentina)
  • Veterquimica S.A. (Chile)
  • Nisseiken Co. Ltd. (Japan)
  • Virbac S.A. (France)
  • Elanco (USA)
  • Kyoritsuseiyaku Corporation (Japan)

Related Industry Reports

Aquaculture Diagnostics Market

Global Aquaculture Market

Global Mediterranean Aquaculture Market

Aquaculture Pharmaceuticals Market